688117 圣诺生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)13.0255.5648.2438.00110.019
总资产报酬率 ROA (%)7.1413.3765.8046.2477.906
投入资产回报率 ROIC (%)7.9213.7966.6847.2419.527

边际利润分析
销售毛利率 (%)56.66957.96663.76165.47071.973
营业利润率 (%)28.36013.60818.64318.40719.613
息税前利润/营业总收入 (%)30.14515.50419.54717.89617.758
净利润/营业总收入 (%)24.41210.92716.16616.29615.847

收益指标分析
经营活动净收益/利润总额(%)101.965119.30296.783101.84498.751
价值变动净收益/利润总额(%)0.6173.045-1.7743.4072.078
营业外收支净额/利润总额(%)-1.256-0.897-1.223-0.659-7.551

偿债能力分析
流动比率 (X)1.4561.3222.5252.9604.013
速动比率 (X)0.9010.7611.7202.3583.389
资产负债率 (%)45.94944.27333.10925.38517.926
带息债务/全部投入资本 (%)34.34537.64423.45211.9664.619
股东权益/带息债务 (%)173.894164.911324.497728.4732,041.479
股东权益/负债合计 (%)117.632125.873201.990293.929457.857
利息保障倍数 (X)14.1077.68417.315-45.787-37.140

营运能力分析
应收账款周转天数 (天)63.67582.64386.15192.32592.768
存货周转天数 (天)380.375468.610376.514311.938317.967